Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease
- PMID: 26378640
- DOI: 10.1055/s-0035-1562943
Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease
Abstract
The epidemic of obesity has resulted in a parallel incremental burden of nonalcoholic fatty liver disease (NAFLD) worldwide. Nonalcoholic fatty liver disease includes a spectrum of liver disease that ranges from simple fat accumulation in the liver to necroinflammation, fibrosis, cirrhosis, and hepatocellular carcinoma, which in essence represent the stages of the natural history of NAFLD. The rising prevalence of NAFLD globally may be accounted for by changes in dietary habits and an increase in sedentary lifestyle. Nonalcoholic steatohepatitis (NASH), the aggressive form of NAFLD, is currently the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. In the current review, the authors discuss the uncertainty around the progression from NAFL (steatosis) to NASH (steatohepatitis), the undisputed progression of NASH to cirrhosis, and the risk factors that predispose to such progression. The published literature on the long-term cardiovascular complications and liver-related mortality of NAFLD is also discussed.
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
Similar articles
-
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation.Liver Transpl. 2018 Feb;24(2):166-170. doi: 10.1002/lt.25003. Liver Transpl. 2018. PMID: 29272073
-
Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.World J Gastroenterol. 2015 Apr 14;21(14):4103-10. doi: 10.3748/wjg.v21.i14.4103. World J Gastroenterol. 2015. PMID: 25892859 Free PMC article. Review.
-
Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.Dig Dis Sci. 2015 Oct;60(10):3142-8. doi: 10.1007/s10620-015-3821-7. Epub 2015 Aug 7. Dig Dis Sci. 2015. PMID: 26250831
-
Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults.Clin Liver Dis. 2016 May;20(2):313-24. doi: 10.1016/j.cld.2015.10.010. Epub 2015 Dec 24. Clin Liver Dis. 2016. PMID: 27063271 Review.
-
Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: A Problem of Growing Magnitude.Semin Liver Dis. 2015 Aug;35(3):304-17. doi: 10.1055/s-0035-1562949. Epub 2015 Sep 17. Semin Liver Dis. 2015. PMID: 26378646 Review.
Cited by
-
Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives.Hepatology. 2017 Jan;65(1):350-362. doi: 10.1002/hep.28709. Epub 2016 Aug 4. Hepatology. 2017. PMID: 27358174 Free PMC article. Review.
-
Heterozygous knockout of Bile salt export pump ameliorates liver steatosis in mice fed a high-fat diet.PLoS One. 2020 Aug 12;15(8):e0234750. doi: 10.1371/journal.pone.0234750. eCollection 2020. PLoS One. 2020. PMID: 32785220 Free PMC article.
-
Non-invasive diagnosis of hepatic steatosis.Hepatol Int. 2017 Jan;11(1):70-78. doi: 10.1007/s12072-016-9772-z. Epub 2016 Oct 25. Hepatol Int. 2017. PMID: 27783208 Review.
-
Hepatocellular Carcinoma: Surgical Management and Evolving Therapies.Cancer Treat Res. 2024;192:185-206. doi: 10.1007/978-3-031-61238-1_10. Cancer Treat Res. 2024. PMID: 39212922 Review.
-
Generation of Human Fatty Livers Using Custom-Engineered Induced Pluripotent Stem Cells with Modifiable SIRT1 Metabolism.Cell Metab. 2019 Aug 6;30(2):385-401.e9. doi: 10.1016/j.cmet.2019.06.017. Cell Metab. 2019. PMID: 31390551 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical